Dr Reddys Laboratories Reaches All-Time High, Showcasing Strong Performance and Growth

Aug 21 2024 09:25 AM IST
share
Share Via
Dr Reddys Laboratories, a leading pharmaceutical company, has reached an all-time high in its stock price on August 21, 2024. According to MarketsMojo, the stock has been given a 'Buy' call and is currently trading at 0.53% below its 52-week high. The company has shown stability and strong performance, with consecutive gains and trading above its moving averages. Despite market volatility, Dr Reddys Laboratories has remained resilient and has a positive outlook for future growth.

Dr Reddys Laboratories, a leading pharmaceutical company, has reached an all-time high in its stock price on August 21, 2024. This is a significant milestone for the company, showcasing its strong performance and growth in the industry.

According to MarketsMOJO, a leading stock market analysis platform, Dr Reddys Laboratories has been given a 'Buy' call, indicating positive sentiment towards the stock. The stock is currently trading at 0.53% below its 52-week high of Rs 7036.25, which is a strong indicator of its consistent performance.

In terms of today's performance, Dr Reddys Laboratories is in line with the overall sector, showing stability and strength in the market. The stock has also been on a consecutive gain for the past 3 days, with a 3.02% increase in returns during this period. This showcases the company's ability to maintain a steady growth trajectory.

Despite the high volatility in the market today, with an intraday volatility of 166.01%, Dr Reddys Laboratories has remained resilient and has traded in a narrow range of Rs 35. This further highlights the company's stability and strong position in the market.

Moreover, Dr Reddys Laboratories is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price. This is a positive sign for investors and showcases the company's consistent growth and performance.

In comparison to the Sensex, Dr Reddys Laboratories has shown a 19.86% increase in its stock price over the past year, while the Sensex has shown a 23.78% increase. This further highlights the company's strong performance and potential for growth in the future.

Overall, Dr Reddys Laboratories has shown a strong and consistent performance in the pharmaceutical industry, making it a promising investment opportunity for investors. With its all-time high stock price and positive outlook, the company is poised for continued success in the market.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read